Taro Pharmaceutical Industries Ltd (NYSE:TARO)

66.95
BATS BZX Real-Time Price
As of Jul 07
 0.00 / 0.00%
Today’s Change
56.07
Today|||52-Week Range
99.69
-23.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Operating ActivitiesNet Income / Starting Line67.4M61.6M89.7M63.2M
 
 
 
 
 
Depreciation4.3M4.4M4.7M5.1M
 
 
 
 
 
Total Other Cash Flow-25.4M16.2M-33.7M16.5M
 
 
 
 
 
Funds From Operations47.9M79.0M63.1M96.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-34.8M5.4M-39.0M31.3M
 
 
 
 
 
Net Cash Flow - Operating Activities82.8M73.6M102.2M65.0M
 
 
 
 
 
 
InvestingIncrease In Investments-107.6M-50.2M---1.2B
 
 
 
 
Decrease In Investments122.0M171.9M19.9M1.1B
 
 
 
 
 
Capital Expenditures-6.1M-6.0M-7.0M-7.9M
 
 
 
 
 
Net Cash Flow Investing8.3M114.7M169.2M-35.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-24.7M-7.5M-38.4M-18.3M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.00-488.9M-11.1M
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-24.7M-7.5M-527.4M-28.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-670.0K516.2K-1.6M620.0K
 
 
 
 
 
 
Net Change In Cash66.4M180.8M-256.0M983.8K